Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02730312
Title PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Xencor, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
Emory University Hospital Midtown Atlanta Georgia 30308 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
Wexner Medical Center at The Ohio State University Columbus Ohio 43210 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field